Taking a medical innovation from the conceptual stage to an approved, clinically and market relevant product takes skill, time and money.
Sarsia's highly experienced team of engineers, technologists, biologists and pharmacologists identify and support, through active ownership, innovative research-based companies working to develop and bring to market products with a high medical need.
Life Science prospects are "born global". With world-class research, investing in the European Life Science sector is an attractive proposition. Sarsia is Norway’s leading early-stage Life Science investment firm investing in Europe with a special focus on the Nordics. We combine our technological knowledge and solid understanding of the market, with a vibrant international network.
Examples of investment areas:
Biomedicine and biotech
Medical instrumentation and technology platforms
Diagnostic tools and biotechnological products
Marine biology and technology related to aquaculture
Latest news about Life Sciences
Wed Jun 25 2025
SonoClear successfully closes a funding round
Our portfolio company SonoClear has closed an oversubscribed funding round of over 45 million NOK. I…
